About Us

Accelovance is an award-winning, proven CRO that provides Flexible Solutions to address clinical needs and meet business objectives.  We operate three core service divisions; Full-Service CRO, Accelovance Clinical Sites and Patient Recruitment that positively impact the productivity, quality and control of clinical research.  The unique ownership of clinical sites as a CRO is the foundation for Accelovance’s “patient-centric” study approach. Accelovance has unparalleled insight to operational efficiencies that in turn enhance productivity and quality, even guaranteeing the budgets, timelines and milestones.

Utilized in independent of one another, or in an integrated manner, our study approaches will traditionally reduce timelines 25-75% from original target and reduce study budgets 15-25%.   Committed to the Sponsors we serve, Accelovance has never missed a timeline or deliverable and has never initiated a change order.  Accelovance’s unique offering and proven performance have been consecutively recognized with the ViE Award for BEST CRO in 2009, 2010 & 2011. 

Our service divisions are flexible to serve Sponsors (Biotech, Small/Mid and Large Pharma) and CROs alike based on study needs.  Established in 2005 with a corporate mission to improve the quality and predictability in clinical research, Accelovance has made significant strides in the industry.  This is a result of combining strong business and operational perspective with clinical and medical expertise. 

How can this level of performance from a committed CRO partner impact your next study?